Mitsubishi Tanabe Pharma Corporation

Datamonitor's Mitsubishi Tanabe Pharma Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. Mitsubishi Tanabe Pharma Corporation - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Mitsubishi Tanabe Pharma (Mitsubishi Tanabe) is primarily engaged in the development, manufacturing, marketing, export and import of ethical drugs, over-the-counter (OTC) drugs and diagnostic agents. The company mainly operates in Japan, where it is headquartered in Osaka and employed 9,266 people as of March 31, 2010. The company recorded revenues of JPY404,747 million ($4,371.3 million*) during the financial year (FY) ended March 2010, a decrease of 2.4% over FY2009. The operating profit of the company was JPY61,475 million ($663.9 million*) during FY2010, a decrease of 14.3% over FY2009. The net profit was JPY30,253 million ($326.7 million*) in FY2010, an increase of 14% over FY2009. * Calculated using the constant conversion rate of JPY1 = $0.0108 during the financial year ended March 31, 2010.

Scope of the Report

• Provides all the crucial information on Mitsubishi Tanabe Pharma Corporation required for business and competitor intelligence needs
• Contains a study of the major internal and external factors affecting Mitsubishi Tanabe Pharma Corporation in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Mitsubishi Tanabe Pharma Corporation
• Data is supplemented with details on Mitsubishi Tanabe Pharma Corporation history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Mitsubishi Tanabe Pharma Corporation

Reasons to Purchase

• Support sales activities by understanding your customers’ businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors’ business structure, strategy and prospects
• Obtain the most up to date company information available